Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FORMA Names Medicinal, CompChemistry VP | Contract Pharma
Breaking News, Promotions & Moves

FORMA Names Medicinal, CompChemistry VP

Dinsmore brings extensive discovery and development expertise

Christopher Dinsmore, Ph.D., has been appointed vice president of Medicinal and Computational Chemistry at FORMA Therapeutics. Dr. Dinsmore joins the company after 19 years with Merck & Co., where he helped build the Merck Research Lab in Boston.
 
Dr. Dinsmore most recently served as executive director of Discovery Chemistry at Merck, where he led the discovery and advancement of seven compounds in clinical development, as well as several additional preclinical candidates. He has held various scientific and managerial leadership positions including membership in strategic committees managing external research partnerships and oncology in-licensing opportunities. 
 
“Chris is an experienced chemist and team leader with a broad background in the identification and development of therapeutics for oncology and cardiovascular diseases, Alzheimer’s, asthma and rheumatoid arthritis,” said Kenneth W. Bair, Ph.D., chief scientific officer and head of R&D at FORMA Therapeutics. “As a founding member of Merck’s Boston site, he helped build highly integrated and collaborative new approaches to discovery research, which is precisely what FORMA strives to accomplish.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters